Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

Getting a prostate cancer diagnosis early is key to better treatment results. Doctors might do an exam and a blood test for prostate cancer screening.

Prostate Cancer: Most Successful Treatment
Prostate Cancer: Most Successful Treatment 4

The stage of cancer when diagnosed is very important. It helps decide the best prostate cancer treatment. We look at different treatments, like surgery and radiation, and even newer options.

Knowing what prostate cancer is and its signs is vital. This helps people get medical help fast. If caught early, prostate cancer treatment is almost always successful.

Key Takeaways

  • Early diagnosis of prostate cancer improves treatment outcomes.
  • The stage of cancer at diagnosis determines the treatment approach.
  • Treatment options include surgery, radiation therapy, and hormone therapy.
  • Advanced therapies offer significant gains for advanced disease.
  • Understanding prostate cancer and its symptoms is critical for timely intervention.

The Current Landscape of Prostate Cancer Treatment

It’s important to know about prostate cancer treatment options. There are many choices based on the cancer’s stage and type.

Prostate Cancer: Most Successful Treatment
Prostate Cancer: Most Successful Treatment 5

How Cancer Stage Influences Treatment Selection

The cancer’s stage at diagnosis is key in choosing treatment. For early-stage cancer, surgery or radiation can be very effective. The Cambridge Prognostic Groups (CPG) help doctors pick the best treatment.

The Gleason score shows how aggressive the cancer is. A higher score means the cancer is more aggressive. Knowing this can help doctors choose the right treatment.

Measuring Treatment Success: Survival and Quality of Life

Success in treating prostate cancer is measured in survival and quality of life. For early-stage cancer, treatments often work well. This means many patients can live a long life after treatment.

Quality of life is also important. Treatments can affect how you urinate, have bowel movements, and have sex. Understanding these effects helps patients make better choices about their care.

Surgical Interventions: Leading Options for Localized Prostate Cancer

For those with localized prostate cancer, surgery is a top choice. It’s a key treatment that has gotten better thanks to new techniques.

We’ll look at the main surgeries for localized prostate cancer. These are radical prostatectomy and robotic-assisted surgery. They are very effective, with a nearly 100% survival rate at five years.

Radical Prostatectomy: Nearly 100% Five-Year Survival Rate

Radical prostatectomy removes the prostate gland. It’s a common treatment for early prostate cancer. Over time, the surgery and care after it have gotten much better.

  • High Success Rate: Radical prostatectomy has a nearly 100% five-year survival rate. It’s a very effective treatment.
  • Nerve-Sparing Techniques: New surgical methods try to keep urinary and sexual function. This is thanks to nerve-sparing techniques.
  • Minimally Invasive: New tech has made surgery less invasive. This means less recovery time and fewer problems.
Prostate Cancer: Most Successful Treatment
Prostate Cancer: Most Successful Treatment 6

Robotic-Assisted Surgery: Reducing Complications

Robotic-assisted surgery is a big step forward in treating prostate cancer. It uses a robotic system to help the surgeon. This makes the surgery more precise and safer.

The benefits of robotic-assisted surgery include:

  1. Enhanced Precision: The robotic system gives a clear, 3D view of the area. This helps the surgeon remove the prostate more accurately.
  2. Reduced Complications: This surgery has fewer complications. There’s less blood loss and a lower chance of infection.
  3. Faster Recovery: Patients usually recover faster with robotic-assisted surgery. This is compared to traditional open surgery.

By using these advanced surgical methods, we can offer patients effective treatments for localized prostate cancer. This improves survival rates and quality of life.

Radiation-Based Treatments for Prostate Cancer

Radiation-based treatments are key in fighting prostate cancer. We use the latest radiation therapies to hit cancer cells hard. This helps keep healthy tissues safe.

External Beam Radiation Therapy (EBRT): Precision and Effectiveness

External Beam Radiation Therapy (EBRT) is a top choice for prostate cancer. It has a nearly 100% five-year survival rate for early-stage cases. EBRT uses a machine outside the body to aim precise radiation at cancer cells.

We use cutting-edge tech in EBRT for better results. This includes IMRT and IGRT. These methods let us make adjustments as we go, ensuring the best treatment.

Brachytherapy: Internal Radiation Approach

Brachytherapy puts tiny radioactive seeds inside the prostate. This method sends high doses of radiation right to the tumor. It helps protect the healthy tissues around it.

Brachytherapy works well for those with low to intermediate-risk prostate cancer. It’s a quick treatment, usually done in one session. It has a high success rate in controlling the disease.

Both EBRT and Brachytherapy are great choices for prostate cancer treatment. We help patients choose the best radiation treatment based on their situation and needs.

Hormone Therapy: Enhancing Treatment Outcomes

Hormone therapy can slow prostate cancer cell growth by lowering testosterone levels. It’s a key part of managing prostate cancer, often used with other treatments.

Androgen Deprivation Therapy (ADT) as Primary and Adjuvant Treatment

Androgen Deprivation Therapy (ADT) is a hormone therapy for prostate cancer. It reduces male hormones in the body. The National Cancer Institute says ADT can be a main treatment or used with other treatments like radiation.

ADT is mainly for high-risk or advanced prostate cancer. It helps slow the disease and improve life quality.

Combining Hormone Therapy with Radiation for Intermediate to High-Risk Disease

For those with intermediate to high-risk prostate cancer, hormone therapy with radiation is better. This combo can boost survival chances and lower cancer coming back.

Hormone therapy can make tumors smaller before radiation. It also helps after radiation to kill any cancer left.

Key benefits of combining hormone therapy with radiation include:

  • Improved survival rates
  • Reduced risk of cancer recurrence
  • Enhanced effectiveness of radiation therapy

Understanding hormone therapy’s role in prostate cancer treatment helps patients make better choices. It’s vital to talk to a healthcare provider about the benefits and risks to find the best treatment.

Advanced Treatments for Metastatic Prostate Cancer

Managing metastatic prostate cancer has changed a lot with new treatments. These changes help patients live longer and feel better. It’s a big step forward in treating this tough disease.

Modern Combination Therapies: ADT with Enzalutamide or Abiraterone

New treatments have changed how we fight metastatic prostate cancer. Using Androgen Deprivation Therapy (ADT) with enzalutamide or abiraterone has been very effective. These methods attack cancer in different ways, helping patients a lot.

  • Enzalutamide slows cancer growth and boosts survival chances.
  • Abiraterone with prednisone greatly improves survival rates.

Combining these treatments gives a better way to fight metastatic prostate cancer. It helps stop cancer growth and improves patients’ health overall.

PARP Inhibitors: Olaparib and Beyond

PARP inhibitors, like olaparib, are a big step forward in treating metastatic prostate cancer. They block the PARP enzyme, stopping cancer cells from fixing their DNA. This stops cancer from growing.

“The introduction of PARP inhibitors has opened new avenues for treating metastatic prostate cancer, specially in patients with specific genetic mutations.”

Olaparib works well for patients with certain genetic changes in their cancer. This targeted treatment is a big step towards personalized care for prostate cancer.

Lutetium-177 PSMA Therapy: Breakthrough for Advanced Cases

Lutetium-177 PSMA therapy is a new hope for advanced prostate cancer. It uses a radioactive ligand that targets cancer cells. This delivers radiation right to the tumor.

  • Shows improved survival rates.
  • Delays radiographic disease progression.

This therapy directly attacks cancer cells, reducing harm to healthy tissue. It offers new hope for patients with advanced metastatic prostate cancer.

Comparing Success Rates Across Treatment Modalities

Prostate cancer treatment success rates vary by treatment type. Outcomes depend on the cancer stage and other factors. It’s key to look at the cancer stage, patient health, and side effects when comparing treatments.

Localized Disease: Surgery vs. Radiation Outcomes

For localized prostate cancer, surgery and radiation therapy have similar survival rates. Radical prostatectomy, a surgery, has a high cure rate, with nearly 100% survival at five years. External Beam Radiation Therapy (EBRT) and Brachytherapy, radiation treatments, also control cancer well.

Research has compared surgery and radiation for localized cancer. Both have benefits and side effects, but survival rates are similar. The choice between surgery and radiation depends on patient preference, health, and cancer details.

Advanced Disease: Combination Therapy Results

For advanced prostate cancer, combination therapy is very effective. Androgen Deprivation Therapy (ADT) with Enzalutamide or Abiraterone improves survival and quality of life. PARP inhibitors like Olaparib also work well for cancers with certain genetic changes.

Lutetium-177 PSMA therapy is showing great promise for advanced cancer. It offers a new option for those with metastatic disease. These combination therapies have greatly improved survival and quality of life for men with advanced cancer.

Conclusion: Finding the Right Prostate Cancer Treatment Approach

Finding the best prostate cancer treatment is complex. It depends on the cancer stage and the person’s health. We’ve looked at many options, like surgery, radiation, hormone therapy, and treatments for advanced cancer.

It’s important to use a team approach for the best results. Healthcare providers should tailor treatments to each patient’s needs. Knowing what causes prostate cancer and its symptoms helps in finding the right treatment.

As we keep improving prostate cancer treatment, a complete approach works best. By using the latest research and medical skills, we can make treatments better. This helps patients with prostate cancer live better lives.

FAQ

What are the most common symptoms of prostate cancer?

Symptoms of prostate cancer include trouble urinating and weak urine flow. You might also urinate more often or feel pain while doing so. But many men with early cancer don’t show symptoms.

What is a Gleason score, and how is it used in prostate cancer treatment?

The Gleason score shows how aggressive prostate cancer is. It’s based on the tumor’s look under a microscope. Doctors use it to predict how the cancer will behave and decide on treatment.

What is the difference between localized and advanced prostate cancer?

Localized cancer stays in the prostate. Advanced cancer spreads to other parts like lymph nodes, bones, or organs.

What are the treatment options for localized prostate cancer?

For localized cancer, you can choose surgery, radiation, or watchful waiting. Surgery removes the prostate, radiation uses beams or tiny seeds, and active surveillance means monitoring closely.

What is enzalutamide, and how is it used in prostate cancer treatment?

Enzalutamide blocks male hormones that help cancer grow. It’s used for advanced cancer, often with other treatments.

What is Lutetium-177 PSMA therapy, and how does it work?

Lutetium-177 PSMA therapy targets and kills cancer cells that have a certain protein. It’s a form of targeted radiation therapy.

What is the prognosis for prostate cancer patients, and how is it determined?

Prognosis depends on the cancer stage, Gleason score, and overall health. Men with early cancer usually have a good outlook. Those with advanced cancer face a tougher road.

What is the role of hormone therapy in prostate cancer treatment?

Hormone therapy lowers male hormones that feed cancer growth. It’s a key treatment, used alone or with other therapies.

How is treatment success measured in prostate cancer?

Success is measured by survival rates, quality of life, and cancer control. The metrics vary based on the case and treatment plan.

What is the significance of a multidisciplinary approach to prostate cancer treatment?

A team approach ensures patients get the best care. It involves doctors, nurses, and other experts working together. This is key for effective treatment.

References

  1. American Cancer Society. (2023). Survival Rates for Prostate Cancer. Retrieved fromhttps://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/survival-rates.html
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01